(Q35118721)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12724730%20AND%20SRC:MED&resulttype=core&format=json

3 November 2019

review article

1 reference

title

Translational strategies for cancer prevention in liver (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12724730%20AND%20SRC:MED&resulttype=core&format=json

3 November 2019

1 reference

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12724730%20AND%20SRC:MED&resulttype=core&format=json

3 November 2019

author name string

Thomas W Kensler

series ordinal

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12724730%20AND%20SRC:MED&resulttype=core&format=json

3 November 2019

Geng-Sun Qian

series ordinal

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12724730%20AND%20SRC:MED&resulttype=core&format=json

3 November 2019

John D Groopman

series ordinal

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12724730%20AND%20SRC:MED&resulttype=core&format=json

3 November 2019

language of work or name

English

0 references

publication date

1 May 2003

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12724730%20AND%20SRC:MED&resulttype=core&format=json

3 November 2019

published in

Nature Reviews Cancer

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12724730%20AND%20SRC:MED&resulttype=core&format=json

3 November 2019

volume

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12724730%20AND%20SRC:MED&resulttype=core&format=json

3 November 2019

issue

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12724730%20AND%20SRC:MED&resulttype=core&format=json

3 November 2019

page(s)

321-329

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12724730%20AND%20SRC:MED&resulttype=core&format=json

Estimates of the worldwide incidence of 25 major cancers in 1990.

3 November 2019

cites work

1 reference

31 March 2020

Cancer statistics, 2003.

1 reference

Chronic hepatitis B virus infection in Asian countries

31 March 2020

1 reference

Hepatocellular carcinoma in the developing world

31 March 2020

1 reference

31 March 2020

1 reference

Modelling the molecular circuitry of cancer

31 March 2020

1 reference

Hypermethylation pathways to colorectal cancer. Implications for prevention and detection

31 March 2020

1 reference

Molecular pathogenesis of human hepatocellular carcinoma

31 March 2020

1 reference

Hepatitis B virus biology

31 March 2020

1 reference

Serologic markers of hepatitis B virus infection

31 March 2020

1 reference

Hepatitis C: virology, epidemiology, clinical course, and treatment

31 March 2020

1 reference

Advances in therapy for hepatitis C infection

31 March 2020

1 reference

Structural identification of the major DNA adduct formed by aflatoxin B1 in vitro

31 March 2020

1 reference

Isolation and characterization of the major serum albumin adduct formed by aflatoxin B1 in vivo in rats

31 March 2020

1 reference

Urinary aflatoxin biomarkers and risk of hepatocellular carcinoma

31 March 2020

1 reference

Increased risk of hepatocellular carcinoma in male hepatitis B surface antigen carriers with chronic hepatitis who have detectable urinary aflatoxin metabolite M1.

31 March 2020

1 reference

Aflatoxin exposure and risk of hepatocellular carcinoma in Taiwan

31 March 2020

1 reference

Effect of aflatoxin metabolism and DNA adduct formation on hepatocellular carcinoma among chronic hepatitis B carriers in Taiwan

31 March 2020

1 reference

Natural history of hepatocellular carcinoma including fibrolamellar and hepato-cholangiocarcinoma variants

31 March 2020

1 reference

The role of serum alpha-fetoprotein estimation in the diagnosis and management of hepatocellular carcinoma

31 March 2020

1 reference

Screening for liver cancer: results of a randomised controlled trial in Qidong, China

31 March 2020

1 reference

Gene expression profiling of preneoplastic liver disease and liver cancer: a new era for improved early detection and treatment of these deadly diseases?

31 March 2020

1 reference

Microsatellite alterations in serum DNA of head and neck cancer patients

31 March 2020

1 reference

Detection of circulating tumour DNA in the blood (plasma/serum) of cancer patients

31 March 2020

1 reference

Hot-spot mutations in hepatitis B virus X gene in hepatocellular carcinoma

31 March 2020

1 reference

Dominant role of hepatitis B virus and cofactor role of aflatoxin in hepatocarcinogenesis in Qidong, China

31 March 2020

1 reference

Molecular pathogenesis of human hepatocellular carcinoma.

31 March 2020

1 reference

The toxicology of aflatoxins as a basis for public health decisions

31 March 2020

1 reference

TP53 and liver carcinogenesis.

31 March 2020

1 reference

Ser-249 p53 mutations in plasma DNA of patients with hepatocellular carcinoma from The Gambia

31 March 2020

1 reference

Universal hepatitis B vaccination in Taiwan and the incidence of hepatocellular carcinoma in children. Taiwan Childhood Hepatoma Study Group

31 March 2020

1 reference

The role of aflatoxins and hepatitis viruses in the etiopathogenesis of hepatocellular carcinoma: A basis for primary prevention in Guinea-Conakry, West Africa

31 March 2020

1 reference

Chemoprevention: an essential approach to controlling cancer

31 March 2020

1 reference

Colorectal cancer prevention and treatment by inhibition of cyclooxygenase-2.

31 March 2020

1 reference

Chemopreventive properties of chlorophylls towards aflatoxin B1: a review of the antimutagenicity and anticarcinogenicity data in rainbow trout

31 March 2020

1 reference

Use of chlorophyllin in the care of geriatric patients

31 March 2020

1 reference

Mechanisms of chlorophyllin anticarcinogenesis against aflatoxin B1: complex formation with the carcinogen

31 March 2020

1 reference

Chlorophyllin intervention reduces aflatoxin-DNA adducts in individuals at high risk for liver cancer

31 March 2020

1 reference

Schistosomiasis: from risk assessment to control

31 March 2020

1 reference

Protective alterations in phase 1 and 2 metabolism of aflatoxin B1 by oltipraz in residents of Qidong, People's Republic of China

31 March 2020

1 reference

The importance of using scientific principles in the development of medicinal agents from plants

31 March 2020

1 reference

The chemical diversity and distribution of glucosinolates and isothiocyanates among plants

31 March 2020

1 reference

A major inducer of anticarcinogenic protective enzymes from broccoli: isolation and elucidation of structure

31 March 2020

1 reference

Broccoli sprouts: an exceptionally rich source of inducers of enzymes that protect against chemical carcinogens

31 March 2020

1 reference

Consumption of Brussels sprouts results in elevated alpha-class glutathione S-transferase levels in human blood plasma.

31 March 2020

1 reference

Preventive effects of drinking green tea on cancer and cardiovascular disease: epidemiological evidence for multiple targeting prevention

31 March 2020

1 reference

Green tea: cancer preventive beverage and/or drug

31 March 2020

1 reference

Oltipraz regenerates cirrhotic liver through CCAAT/enhancer binding protein-mediated stellate cell inactivation

31 March 2020

1 reference

Prevention of second primary tumors by an acyclic retinoid, polyprenoic acid, in patients with hepatocellular carcinoma. Hepatoma Prevention Study Group

31 March 2020

1 reference

Chemoprevention of hepatocellular carcinoma: concept, progress and perspectives.

31 March 2020

1 reference

Multiple mutations and cancer

31 March 2020

1 reference

Development of cancer chemopreventive agents: oltipraz as a paradigm

31 March 2020

1 reference

Modulation of gene expression by cancer chemopreventive dithiolethiones through the Keap1-Nrf2 pathway. Identification of novel gene clusters for cell survival

31 March 2020

1 reference

An Nrf2/Small Maf Heterodimer Mediates the Induction of Phase II Detoxifying Enzyme Genes through Antioxidant Response Elements

31 March 2020

1 reference

Keap1 represses nuclear activation of antioxidant responsive elements by Nrf2 through binding to the amino-terminal Neh2 domain

31 March 2020

1 reference

Direct evidence that sulfhydryl groups of Keap1 are the sensors regulating induction of phase 2 enzymes that protect against carcinogens and oxidants

31 March 2020

1 reference

Interactive effects of nrf2 genotype and oltipraz on benzo[a]pyrene-DNA adducts and tumor yield in mice

31 March 2020

1 reference

Sensitivity to carcinogenesis is increased and chemoprotective efficacy of enzyme inducers is lost in nrf2 transcription factor-deficient mice

31 March 2020

1 reference